Live Quote · NASDAQOVIDHealthcare· Biotechnology

Ovid Therapeutics Inc.

$2.20▼ 5.98%($-0.14)
MKT CAP $415.21MNEXT EARNINGS Mar 15, 2027
50%
Bullish
TickerSpark Score
59/100
▌ Mixed
40
Valuation
40
Profitability
100
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OVID research report →

Analyst Price Target
$6.25+184.1% vs. today

Range $5 – $8

Analyst RatingBuy
11 Buy3 Hold0 Sell

Price Chart

+80.33% · this period
$2.96$2.09$1.22Nov 20May 26Nov 20
52-Week Range51% of range
Low
$1.26
Current
$2.20
High
$3.11